Not provided
Not provided
Not provided
Not provided
Excess of serious adverse events in the endoscopic laser resection group
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Multicenter randomized controlled trial comparing endoscopic laser resection vs dilatation in benign tracheal stenosis.
An observational study suggests the superiority of endoscopic laser resection over dilatation in idiopathic tracheal stenosis but little litterature has been published on the subject. Hence we decided to design a prospective multicenter open label randomized controlled trial to compare the two interventions. Patients refered for endoscopic treatment of a simple benign tracheal stenosis will be randomized to endoscopic laser resection or dilatation. Randomisation will be stratified for center, type of stenosis (idiopathic vs other) and history of previous endoscopic treatment. Patients will be blinded to treatment but not physician. All patients will be treated with proton pump inhibitors.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endoscopic laser resection | Experimental | Using CO2, diode or similar wavelenght laser the stenotic tracheal segment will be vaporized allowing a less than 20% residual stenosis. Dilatation will not be performed after laser resection for residual stenosis. |
|
| Dilatation | Experimental | Using a ballon or rigid bronchoscope the stenotic tracheal segment will be dilated with or without previous radial incision with electrocautery or laser. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Endoscopic laser resection | Procedure | Laser resection |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Relapse rate at 2 years of symptomatic tracheal stenosis (> 40%) requiring a new procedure | Within 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Relapse rate at 1 year of symptomatic tracheal stenosis (> 40%) requiring a new procedure | 1 year | |
| Time to first symptomatic relapse of tracheal stenosis | 2 years | |
| Measure | Description | Time Frame |
|---|---|---|
| Relapse rate at 2 years of symptomatic tracheal stenosis (> 40%) requiring a new procedure in the idiopathic and non idiopathic subroup as well as in the first episode and recurrence subgroups | 2 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marc Fortin | Fondation IUCPQ | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) | Québec | Canada | ||||
| Centre Hospitalier Universitaire Grenoble Alpes |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35301206 | Derived | Soumagne T, Guibert N, Atallah I, Lacasse Y, Dutau H, Fortin M. Dilation versus laser resection in subglottic stenosis: protocol for a prospective international multicentre randomised controlled trial (AERATE trial). BMJ Open. 2022 Mar 17;12(3):e053730. doi: 10.1136/bmjopen-2021-053730. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014135 | Tracheal Stenosis |
| ID | Term |
|---|---|
| D014133 | Tracheal Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D004106 | Dilatation |
| ID | Term |
|---|---|
| D008919 | Investigative Techniques |
Not provided
Not provided
Randomized Controlled Trial
Not provided
Not provided
Not provided
| Dilatation |
| Procedure |
Dilatation |
|
| mMRC |
| 2 years |
| VAS | 2 years |
| Clinical COPD questionnaire | 2 years |
| VHI-10 | 2 years |
| SF-12 | 2 years |
| Measurement of stenosis by cephalo-caudal length at endoscopic follow-up at 1 year | Within 2 years |
| Rate of surgical resection following symptomatic recurrence | 2 years |
| Rate and type of complications and adverse effects depending on the procedure | 2 years |
| Grenoble |
| France |
| Hôpital Nord | Marseille | France |
| Hôpital Larrey, University Hospital of Toulouse | Toulouse | France |